SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-019224
Filing Date
2020-07-15
Accepted
2020-07-15 20:19:55
Documents
2
Period of Report
2020-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10027
2 EX-24 DOCUMENT attachment1.htm EX-24 4506
  Complete submission text file 0000899243-20-019224.txt   15935
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RELAY THERAPEUTICS, INC. 399 BINNEY STREET CAMBRIDGE MA 02139
Business Address
Murcko Mark (Reporting) CIK: 0001816130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39385 | Film No.: 201030498